• Blog
  • x

    We are working from home under lockdown. Our team is continuously tracking the impact of COVID-19 across different industries and we will incorporate those insights in our reports. For any specific query, mail us at [email protected]

    Synthetic Biology Market | Covid-19 Impact Analysis

    Synthetic Biology Market | Covid-19 Impact Analysis

    Synthetic Biology Market | Covid-19 Impact Analysis
    Report code - SRHL162 Delivery - 2 Weeks
    Synthetic Biology Market Size, Share, Trend, Forecast, & Industry Analysis
    See more...
    Purchase Report
    notch

    Synthetic Biology Market Insights

    Synthetic Biology Market is likely to witness an impressive CAGR of 23.9% during the forecast period. Increasing use of synthetic biology for various applications such as biofuel development, protein therapeutics, personalized medicine, and synthetic drugs & vaccines is one of the prime factors contributing to the demand for synthetic biology. Large scale adoption of synthetic biology coupled with decreasing cost of DNA sequencing & synthesis of genes resulting in increasing investment in companies and start-ups is another crucial factor fueling the growth of the market.

    Synthetic Biology Market - Snapshot

    Growth

    23.9% for the next five years

    Major Tool Type

    Oligonucleotides & Synthetic DNA

    Dominant Technology Type

    Genome Engineering

    Largest Application Type

    Medical

    Region with the highest demand

    Asia-Pacific

    Key Players

    Agilent Technologies, Inc., Amyris, Inc., Codexis, Inc., Creative Enzymes, Cyrus Biotechnology Inc., Eurofins Scientific, GenScript Biotech Corporation, Ginkgo Bioworks, Integrated DNA Technologies, Inc., New England Biolabs, Novozymes A/S, Precigen, Inc., Synthego Corporation, Synthetic Genomics, Inc., The Merck Group, Thermo Fisher Scientific Inc., and Twist Bioscience

    Wish to Get a Free Sample? Click here

    Market Share Analysis

    Synthetic Biology Market Share: By Tool Type

    Based on the tool type, the market is segmented as oligonucleotides & synthetic DNA, enzymes, cloning technology kits, synthetic cells, chassis organisms, and xeno-nucleic acids. The oligonucleotides & synthetic DNA segment held the largest share of the market in 2019, and is expected to remain dominant during the forecast period. The growing demand for synthetic DNA, synthetic RNA, and synthetic genes, which are used in a wide range of research applications is propelling the segment’s market.

    Synthetic Biology Market Share: By Technology Type

    Based on the technology type, the synthetic biology market is segmented as gene synthesis, genome engineering, sequencing, bioinformatics, cloning, site-directed mutagenesis, measurement & modeling, microfluidics, and nanotechnology. The genome engineering segment is expected to grow at the highest rate in the market, owing to its superior properties as compared to other technologies. Synthetic biology is a preferred choice in genome engineering as it offers ease and efficiency in genome editing and genome targeting.

    Synthetic Biology Market Share: By End-Use Industry Type

    Based on the end-use industry type, the market is segmented as medical, industrial, food & agriculture, and environmental. The medical segment is expected to grow at the highest rate in the market over the forecast period. With growing population and increased life expectancy comes increased occurrence of disease, which demands better, newer, and more efficient modalities of treatments. Increasing focus towards research & development for better treatments along with huge private and public funding for the discovery of new therapies is a key factor driving the growth of the synthetic biology market for medical applications.

    Synthetic Biology Market Share: By Region

    In terms of regions, Asia-Pacific is estimated to be the largest market during the forecast period, with China, Japan, India, and Australia being the major countries with lucrative growth opportunities. This growth can be attributed to the presence of major synthetic biology companies in the region. Availability of funds for research from government organizations, advancing efforts to increase the output of the healthcare industry, rising demand for high-quality research tools for data reproducibility, and increasing focus on development of personalized therapeutics are some prime factors driving the region’s synthetic biology market.

    Some key players in the synthetic biology market are Agilent Technologies, Inc., Amyris, Inc., Codexis, Inc., Creative Enzymes, Cyrus Biotechnology Inc., Eurofins Scientific, GenScript Biotech Corporation, Ginkgo Bioworks, Integrated DNA Technologies, Inc., New England Biolabs, Novozymes A/S, Precigen, Inc., Synthego Corporation, Synthetic Genomics, Inc., The Merck Group, Thermo Fisher Scientific Inc., and Twist Bioscience.

     

    Market Scope & Segmentation

    Synthetic biology is an advanced technology that is developed from biology, engineering, chemistry, and computer science and mainly uses two approaches: top down approach and bottom up approach. The top-down approach involves the re-designing and fabrication of existing biological systems for producing synthetic products, whereas the bottom-up approach involves designing and construction of novel biological systems that do not exist in nature. Aid from government as well as private organizations, rising number of synthetic biology research entities and declining cost of DNA sequencing & synthesizing are the major factors acting as a catalyst towards the imminent need to understand the functioning of genetic elements, cells and biological processes.

    This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.

    Synthetic Biology Market Research Report - Features

    Market Segmentation

    4

    Regions Covered

    4

    Countries/Sub-Regions Covered

    17

    No. of Figures & Tables

    >150

    Company Profiles

    10

    Wish to Get a Free Sample? Click here

    The synthetic biology market is segmented into the following categories. 

    Synthetic Biology Market Size, Share, & Forecast, by Tool Type:

    • Oligonucleotides & Synthetic DNA (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Enzymes, Cloning Technology Kits (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Synthetic Cells (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Chassis Organisms (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Xeno-Nucleic Acids (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)

    Synthetic Biology Market Size, Share, & Forecast, by Technology Type:

    • Gene Synthesis (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Genome Engineering (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Sequencing (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Bioinformatics (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Cloning (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Site-Directed Mutagenesis (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Measurement & Modeling (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Microfluidics (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Nanotechnology (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)

    Synthetic Biology Market Size, Share, & Forecast, by End-Use Industry Type:

    • Medical 
      • (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
      • (End-Use Industry Type Analysis: Pharmaceuticals, Drug Discovery & Therapeutics, Artificial Tissue & Tissue Regeneration)
    • Industrial
      • (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
      • (End-Use Industry Type Analysis: Biofuel and Renewable Energy, Industrial Enzymes, and Biomaterials & Green Chemicals)
    • Food & Agriculture (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Environmental
      • (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
      • (End-Use Industry Type Analysis: Bioremediation and Biosensing)

    Synthetic Biology Market Size, Share, & Forecast, by Region:

    • North America (Country Analysis: the USA, Canada, and Mexico) 
    • Europe (Country Analysis: Germany, France, the UK, Russia, Spain, and Rest of Europe)
    • Asia-Pacific (Country Analysis: China, Japan, India, South Korea, and Rest of Asia-Pacific)
    • Rest of the World (Sub-Region Analysis: Latin America, the Middle East, and Others)

     

    Research Methodology

    This report offers high-quality insights and is the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact book, press release, journals, investor presentation, white papers, patents, and articles have been leveraged to gather the data. We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both the qualitative and quantitative insights.

     

    Report Features

    This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:

    • Market structure: Overview, industry life cycle analysis, supply chain analysis
    • Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
    • Market trend and forecast analysis
    • Market segment trend and forecast
    • Competitive landscape and dynamics: Market share, product portfolio, product launches, etc.
    • Attractive market segments and associated growth opportunities
    • Emerging trends
    • Strategic growth opportunities for the existing and new players
    • Key success factors

     

    Report Customization Options

    With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to 3 players)
    • SWOT analysis of key players (up to 3 players)

    Market Segmentation

    • Current market segmentation of any one of the tool types by end-use industry types.  

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances

    Custom Research: Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected]


    Frequently Asked Questions (FAQs)

    What will be the growth of Synthetic Biology Market in the foreseeable future?

    Driven by the factors like Increasing use of synthetic biology for various applications such as biofuel development, the synthetic biology market is expected to grow at a CAGR of 23.9% in the foreseeable years.

    Who are the key players in the Synthetic biology Market?

    Agilent Technologies, Inc., Amyris, Inc., Codexis, Inc., Creative Enzymes, Cyrus Biotechnology Inc., Eurofins Scientific, GenScript Biotech Corporation, Ginkgo Bioworks, Integrated DNA Technologies, Inc., New England Biolabs, Novozymes A/S, Precigen, Inc., Synthego Corporation, Synthetic Genomics, Inc., The Merck Group, Thermo Fisher Scientific Inc., and Twist Bioscience are among the key players in the synthetic biology market.

    Which type of tool is expected to remain dominant in the Synthetic Biology Market?

    The oligonucleotides & synthetic DNA segment is expected to remain dominant tool type in the synthetic biology market.

    Which country/region is expected to remain the largest market in the Synthetic Biology Market?

    Asia-Pacific is expected to remain the largest synthetic biology market during the next five years.

    •   
    FREE SAMPLE